We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$945M
AUM Growth
+$66.7M
Cap. Flow
+$6.04M
Cap. Flow %
0.64%
Top 10 Hldgs %
68.38%
Holding
92
New
2
Increased
34
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.2M
2
CL icon
Colgate-Palmolive
CL
+$2.85M
3
K
Kellanova
K
+$2.22M
4
BAX icon
Baxter International
BAX
+$1.48M
5
AMGN icon
Amgen
AMGN
+$1.37M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$4.29M
2
ORCL icon
Oracle
ORCL
+$2.51M
3
PEP icon
PepsiCo
PEP
+$2.27M
4
SLB icon
SLB Ltd
SLB
+$2.14M
5
CLX icon
Clorox
CLX
+$1.92M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.52%
2 Healthcare 18.92%
3 Energy 9.17%
4 Industrials 5.89%
5 Financials 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
76
Halliburton
HAL
$26.2B
$735K 0.08%
18,700
-10,400
-36% -$506K
ADI icon
77
Analog Devices
ADI
$180B
$638K 0.07%
11,500
-7,300
-39% -$373K
KMI
78
DELISTED
KINDER MORGAN,INC
KMI
$632K 0.07%
+14,941
New +$632K
DD icon
79
DuPont de Nemours
DD
$19B
$495K 0.05%
4,289
-2,803
-40% -$342K
AA icon
80
Alcoa
AA
$11.7B
$437K 0.05%
11,527
KKD
81
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$394K 0.04%
20,000
PGI
82
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
$300K 0.03%
28,300
-600
-2% -$6.53K
AEG icon
83
Aegon
AEG
$13.5B
$133K 0.01%
25,751
SYPR icon
84
Sypris Solutions
SYPR
$44M
$31K ﹤0.01%
12,000
-11,000
-48% -$32.1K
CLX icon
85
Clorox
CLX
$12.1B
-19,945
Closed -$1.92M
GSK icon
86
GSK
GSK
$107B
-27,097
Closed -$1.56M
ITW icon
87
Illinois Tool Works
ITW
$85.3B
-10,500
Closed -$886K
WBA
88
DELISTED
Walgreens Boots Alliance
WBA
-23,440
Closed -$1.39M

Similar funds

Cullinan Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Cullinan Associates held 92 positions worth $945M, up 7.6% from $878M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Cullinan Associates's Q4 2014 filing shows 2 new, 34 increased, 45 reduced and 4 closed positions. Its largest new stake was Kellanova: 36,902 shares worth $2.27M. The largest sale was Coca-Cola, an estimated $4.29M.

By sector, the portfolio is most concentrated in Consumer Staples at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Energy.

  • Cullinan Associates's largest Q4 2014 buy was Kellanova: 36,902 shares worth $2.27M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q4 2014, an estimated $18.2M increase.
  • Cullinan Associates's biggest Q4 2014 reduction was Coca-Cola, cutting an estimated $4.29M.
  • Cullinan Associates fully exited Clorox in Q4 2014, selling an estimated $1.92M.
  • Cullinan Associates's ten largest holdings make up 68% of its $945M portfolio in Q4 2014.
  • Cullinan Associates opened 2 new positions and closed 4 in Q4 2014.
  • Cullinan Associates's portfolio value rose 7.6% quarter-over-quarter to $945M.

Based on Cullinan Associates's 13F filing for Q4 2014, filed 21 Jan 2015.